5Pezzilli R,Billi P, Migliori M, .et al. Clinical value of pancreatitis-associated protein in acute pancreatitis [J]. Am J Gastroenterol, 1997, 92(10): 1887-1890.
6Hoffmann JA, Kafatos FC, Janeway CA, et al. Phylogenetic perspectives in innate immunity [J]. Science, 1999, 284(5418): 1313-1318.
8Pezzilli R, Morselli-Labate AM, d'Alessandro A, et al. Timecourse and clinical value of the urine trypsinogen-2 dipstick test in acute panereatitis [J]. Eur J Gastroenterol Hepatol, 2001, 13 (3) : 269-274.
9Lempinen M, Stenman UH, Finne P, et al. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis[J]. J Surg Res, 2003, 111(2): 267-273.
10Johnson CD, Lempinen M, Imrie CW, et al. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis [J]. Br J Surg, 2004, 91(8): 1027-1033.
二级参考文献17
1Makoto O. Prediction of severity in acute pancreatitis by signs and symptoms at admission. Pancreas ,2004,29:7.
2Pooran N,Indaram A,Singh P,et al. Cytokines (IL-6 ,IL-8 ,TNF) :early and reliable predictors of severe acute pancreatitis. J Clin Gastroenterol, 2003,37 : 263 -266.
3Pezzilli R, Melzi d' Eril GV, Morselli-Labate AM, et al. Serum amyloid A,procalcitonin,and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci ,2000,45 : 1072-1078.
4Tsunao I, Shigeki T, Hitoshi Y, et al. Significance of measurement of high-sensitivity C-reactive protein in acute pancreatitis. J Gastroenterol, 2002,37 : 935 -938.
5Berney T, Gasche Y, Robert J,et al. Serum profiles of interleukin-6,interleukin-8, and interleukin-10 in patients with severe and mild acute panereatitis. Pancreas, 1999,18:371-377.
6Riche FC, Cholley BP, Laisne M J, et al. Inflammatory cytokines, C reactive protein ,and precalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery,2003,133:257-262.
7Mayer JM, Raraty M, Slavin J, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg,2002,89 : 163-171.
